Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?
Abstract Background Lung cancer is the leading cause of cancer-related deaths worldwide. Therefore, the search for new biomarkers continues in order to diagnose lung cancer at an early stage. In this study, we investigated blood levels of G-protein associated membrane estrogen receptor (GPER)-1 and...
Saved in:
Main Authors: | Aykut Eliçora, Berrak Güven, Hüseyin Engin, Gokcen Tugba Çevik, Hüseyin Fatih Sezer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Cardiothoracic Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13019-024-03296-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction of GPER-1 with the endocrine signaling axis in breast cancer
by: Luis Molina Calistro, et al.
Published: (2025-01-01) -
Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01) -
Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression
by: Chongwu He, et al.
Published: (2024-12-01) -
The Serum Biomarkers in Ulcerative Colitis
by: Semih SEZER, et al.
Published: (2024-12-01) -
Detection of serum composition in pediatric inflammatory multisystem syndrome associated with SARS-CoV-2 and the response for the treatment by FTIR
by: Joanna Depciuch, et al.
Published: (2025-02-01)